Cargando…

COVID-19 vaccination in patients with α1-antitrypsin deficiency

Detalles Bibliográficos
Autores principales:	Yang, Chengliang, Zhao, Hedi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331076/ https://www.ncbi.nlm.nih.gov/pubmed/34147141 http://dx.doi.org/10.1016/S2213-2600(21)00271-X

Ejemplares similares

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
por: Yang, Chengliang, et al.
Publicado: (2021)

Leave no one behind: inclusion of alpha-1 antitrypsin deficiency patients in COVID-19 vaccine trials
por: Yang, Chengliang, et al.
Publicado: (2022)

Association of SARS-CoV-2 infection and persistence with long COVID
por: Yang, Chengliang, et al.
Publicado: (2023)

Update on α(1)-antitrypsin deficiency
por: Ferrarotti, Ilaria, et al.
Publicado: (2018)

Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study
por: Rodríguez Hermosa, Juan Luis, et al.
Publicado: (2023)

Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency
por: Teckman, Jeffrey, et al.
Publicado: (2014)

Ruptured Gastric Aneurysm in α-1 Antitrypsin Deficiency
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2016)

Molecular Mechanism of Z α1-Antitrypsin Deficiency
por: Huang, Xin, et al.
Publicado: (2016)

α(1)-Antitrypsin deficiency and chronic respiratory disorders
por: Cazzola, Mario, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Deficiency and COVID-19 Infection
por: Strassmair, Michael, et al.
Publicado: (2021)

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

Relationship Between α(1)-Antitrypsin Deficiency and Ascending Aortic Distention
por: Dako, Farouk, et al.
Publicado: (2021)

The emerging role of proteases in α(1)-antitrypsin deficiency and beyond
por: Fazleen, Aishath, et al.
Publicado: (2021)

Stem cell-based therapy for α(1)-antitrypsin deficiency
por: Rashid, S Tamir, et al.
Publicado: (2012)

Deficiency of α-1-antitrypsin influences systemic iron homeostasis
por: Ghio, Andrew J, et al.
Publicado: (2013)

Flecainide and elevated liver enzymes in α1-antitrypsin deficiency
por: Jenkins, David J.A., et al.
Publicado: (2016)

The effect of exacerbations on lung density in α(1)-antitrypsin deficiency
por: Strange, Charlie, et al.
Publicado: (2023)

Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation
por: Yang, Chengliang, et al.
Publicado: (2020)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

Long COVID: the next public health crisis is already on its way
por: Yang, Chengliang, et al.
Publicado: (2023)

Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children
por: Yang, Chengliang, et al.
Publicado: (2021)

COVID-19 vaccines for patients with haematological conditions
por: Sun, Clare, et al.
Publicado: (2021)

COVID-19 vaccination in patients receiving dialysis
por: Wilde, Benjamin, et al.
Publicado: (2021)

COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
por: Calle Rubio, Myriam, et al.
Publicado: (2023)

Diagnosis and management of α(1)-antitrypsin deficiency in Europe: an expert survey
por: Horváth, Ildikó, et al.
Publicado: (2019)

Diagnosing α(1)-antitrypsin deficiency: how to improve the current algorithm
por: McElvaney, Noel G.
Publicado: (2015)

α(1)-Antitrypsin deficiency associated with increased risk of heart failure
por: Winther, Sine V., et al.
Publicado: (2023)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Ensuring global access to COVID-19 vaccines
por: Yamey, Gavin, et al.
Publicado: (2020)

Lung microhaemorrhage drives oxidative/inflammatory damage in α(1)-antitrypsin deficiency
por: Saltini, Cesare, et al.
Publicado: (2023)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency
por: Schmid, ST, et al.
Publicado: (2012)

An issue of trust—vaccinating Black patients against COVID-19
por: Okorodudu, Dale O, et al.
Publicado: (2021)

Covid-19 vaccine apps should deliver more to patients
por: Dasgupta, Nabarun, et al.
Publicado: (2021)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
por: Nygren, David, et al.
Publicado: (2022)

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vefru12n53h3icoo5dnire46te